1000189382.jpg

Answer this

Reading File

Finding Sources

Reading File

Finding Sources

Here are complete answers to all questions from your exam paper:

LONG QUESTIONS

LONG 1a) Physiology and Abnormalities of Puerperium

Definition

The puerperium (postpartum period) is the time from delivery of the placenta until the mother's body returns to its pre-pregnant state - conventionally 6 weeks after delivery. It begins at the end of the third stage of labor.

Physiology of Puerperium

1. Uterine Involution

Immediately after delivery, the uterus weighs ~1000 g; by 6 weeks it returns to ~60 g
Fundus is at the umbilicus immediately post-delivery; descends 1 cm/day
By day 5-7: firm, non-tender, midway between symphysis and umbilicus
By 2 weeks: no longer palpable abdominally
Mechanism: myometrial cell autolysis + proteolytic enzymes; ischemia due to vasoconstriction
Breastfeeding promotes involution via oxytocin release

2. Lochia (Vaginal Discharge)

Stage	Timing	Character
Lochia rubra	Days 1-4	Bright red, bloody
Lochia serosa	Days 4-10	Pinkish-brown, serous
Lochia alba	Day 10 onward	Pale yellow-white, minimal
Total duration: 4-6 weeks. Offensive odor suggests infection.

3. Cervix and Vagina

Cervix regains tone within 1 week; external os remains slightly patulous (slit-like, unlike the circular os in nulliparae)
Vaginal rugae return by 3-4 weeks; full restoration by 6 weeks (longer if breastfeeding due to low estrogen)

4. Cardiovascular Changes

Cardiac output remains elevated for 48-72 hours post-delivery (autotransfusion from uteroplacental blood)
Pulse rate drops to normal within 1-2 weeks
Blood pressure returns to normal; WBC count rises (up to 20,000/µL) in first 24 hours (physiologic leukocytosis)
Hematocrit may appear falsely elevated due to diuresis-induced plasma volume decrease

5. Urinary System

Massive diuresis occurs in the first 12-24 hours (loss of pregnancy-related fluid retention)
Glycosuria and proteinuria may be present transiently
Bladder tone may be reduced - risk of urinary retention/overdistension

6. Endocrine Changes

hCG drops to zero by day 10-12
Progesterone falls rapidly after placental delivery; menstruation returns at 6-8 weeks (non-breastfeeding) or 6 months+ (breastfeeding)
Prolactin elevated during lactation; suppresses GnRH - responsible for lactational amenorrhea

7. Lactation

Colostrum (high IgA, protein) secreted from day 1-3
Mature milk from ~day 3-5 (milk "let down" triggered by suckling via prolactin and oxytocin)
Breastfeeding benefits: passive immunity, uterine involution, contraceptive effect

8. Psychological/Emotional Changes

Days 1-3: "Baby blues" (transient mood lability, weeping) - normal
Must be distinguished from postpartum depression (>2 weeks, significant impairment)

Abnormalities of Puerperium

1. Postpartum Hemorrhage (PPH)

Primary PPH: >500 mL blood loss within 24 hours of vaginal delivery (>1000 mL after CS)
Causes: 4 Ts - Tone (uterine atony - 80%), Trauma (lacerations), Tissue (retained placenta), Thrombin (coagulopathy)
Management: uterine massage, oxytocin 10 IU IM/IV, ergometrine, misoprostol, surgical (Bakri balloon, B-Lynch suture, hysterectomy)
Secondary PPH: >24 hours to 12 weeks post-delivery; usually due to retained products or infection

2. Puerperal Pyrexia (Infection)

Fever >38°C on 2 of the first 10 days postpartum (excluding the first 24 hours)
Sources: Endometritis (most common), UTI, mastitis, wound infection, deep vein thrombosis
Endometritis: foul-smelling lochia, uterine tenderness, fever; treat with broad-spectrum antibiotics (ampicillin + gentamicin + metronidazole)
Mastitis: unilateral breast pain, erythema, fever; treat with dicloxacillin/flucloxacillin; continue breastfeeding

3. Subinvolution of Uterus

Failure of uterus to return to normal size; due to retained products, infection
Features: large, soft, tender uterus; prolonged lochia
Treatment: ergometrine, antibiotics if infection, evacuation if retained products

4. Puerperal Psychosis

Rare (1-2 per 1000); onset within 2 weeks; hallucinations, delusions, bizarre behavior
Psychiatric emergency - requires hospitalization

5. Deep Vein Thrombosis / Pulmonary Embolism

Hypercoagulable state persists for 6 weeks postpartum
PE is a leading cause of maternal mortality
Prophylaxis with LMWH in high-risk women; anticoagulation for treatment

6. Urinary Complications

Retention, stress incontinence (due to pelvic floor damage), fistula (vesicovaginal after prolonged labor)

1b) Brief about Post-Partum Contraception

Key principle: Contraception should be offered before discharge, as ovulation can return as early as 3-4 weeks postpartum in non-breastfeeding women.

Method	Timing	Notes
LAM (Lactational Amenorrhea Method)	Immediately	>98% effective if: fully breastfeeding + amenorrheic + <6 months postpartum
Progesterone-only pill (POP)	After 6 weeks (breastfeeding); after 3 weeks (non-BF)	Safe in lactation; does not affect milk supply
DMPA (Depo-Provera)	6 weeks (BF); 3 weeks (non-BF)	150 mg IM every 3 months
Copper IUD	Within 48 hours OR after 4 weeks	Most effective reversible method; safe in BF
Levonorgestrel IUD	After 4 weeks	Safe in BF
Implant (Nexplanon)	After 4 weeks (BF); immediately (non-BF)	Highly effective
Combined OCP	After 6 weeks (BF); 3 weeks (non-BF)	Avoid <6 weeks in BF - estrogen reduces milk supply; also VTE risk in first 21 days
Barrier methods	Immediately	Condoms, diaphragm (wait until involution complete)
Sterilization (tubal ligation)	Immediate postpartum or interval	Permanent; consent must be pre-labor
Male sterilization (vasectomy)	Anytime	3 months for effectiveness

WHO MEC Categories reminder: Estrogen-containing methods are Category 4 (absolutely contraindicated) in breastfeeding women <6 weeks postpartum.

LONG 2) Physiology of Fertilization, Ovulation, Implantation, Menstruation, Gametogenesis

A. Gametogenesis

Spermatogenesis (male):

Occurs in seminiferous tubules; takes ~74 days
Spermatogonia (2n) -> Primary spermatocytes -> (Meiosis I) -> Secondary spermatocytes -> (Meiosis II) -> Spermatids -> (Spermiogenesis) -> Spermatozoa (n)
Driven by FSH (acts on Sertoli cells) and LH (acts on Leydig cells to produce testosterone)
Produces 300 million sperm/ejaculate

Oogenesis (female):

Begins in fetal life; oogonia enter meiosis I but arrest at prophase I (primary oocytes) at birth
At puberty, one primary oocyte completes meiosis I per cycle just before ovulation -> secondary oocyte + first polar body
Meiosis II completes only after fertilization -> ovum + second polar body
Only ~400 oocytes ovulate out of 2 million primordial follicles at birth

B. Ovulation

Follicular Development:

Primordial -> Primary -> Secondary -> Graafian (preovulatory) follicle under FSH influence
Rising estrogen from granulosa cells causes LH surge (positive feedback)

Ovulation:

Occurs ~36 hours after the LH surge (day 14 in a 28-day cycle)
LH surge causes the Graafian follicle to rupture and release the secondary oocyte
Signs: mid-cycle pain (Mittelschmerz), slight temperature rise (0.2-0.5°C), mucus becomes clear/spinnbarkeit

C. Menstrual Cycle Physiology

Phase	Days	Events
Menstruation	1-5	Endometrial shedding; estrogen and progesterone low
Proliferative (Follicular)	6-13	Rising estrogen -> endometrial proliferation; cervical mucus watery
Ovulation	Day 14	LH surge -> follicle rupture
Secretory (Luteal)	15-28	Corpus luteum secretes progesterone -> endometrial glandular secretion; prepares for implantation
Menstruation	Day 28+	If no fertilization: corpus luteum degenerates -> progesterone falls -> endometrium sheds

D. Fertilization

Occurs in the ampulla of the fallopian tube
Sperm must undergo capacitation (6-8 hours in female tract) to acquire fertilizing ability
Acrosome reaction (release of acrosomal enzymes: hyaluronidase, acrosin) allows sperm to penetrate corona radiata and zona pellucida
Fusion of sperm with oocyte membrane triggers:
1. Zona reaction (release of cortical granules) - prevents polyspermy
2. Completion of meiosis II of the oocyte
3. Formation of male and female pronuclei -> fusion -> zygote (46 chromosomes)

E. Implantation

Zygote undergoes cleavage while traveling down the fallopian tube over 3-4 days
Reaches uterus as a 16-cell morula, becomes a blastocyst by day 4-5
Zona pellucida hatches on day 5-6
Implantation begins on day 6-7 post-fertilization (day 20-21 of the menstrual cycle)
Site: posterior wall of the upper uterine body (most common)
Stages:
1. Apposition - blastocyst loosely contacts endometrium
2. Adhesion - trophoblast cells firmly adhere
3. Invasion - syncytiotrophoblast erodes decidua (implantation complete by day 9-10)
Trophoblast produces hCG from day 8-10, which rescues the corpus luteum to maintain progesterone

SHORT QUESTIONS

Short 1) Vaccination in Pregnancy

Principles:

Live attenuated vaccines: generally contraindicated in pregnancy (theoretical risk to fetus)
Inactivated/killed vaccines and toxoids: safe in pregnancy
Timing matters; some vaccines are best given in 2nd/3rd trimester

Vaccine	Recommendation	Timing
Tdap (Tetanus, diphtheria, acellular pertussis)	Recommended every pregnancy	27-36 weeks (protects newborn via antibody transfer)
Influenza (inactivated)	Recommended every pregnancy	Any trimester (especially 2nd/3rd)
COVID-19 (mRNA)	Recommended	Any trimester
Hepatitis B	Recommended if not immune	Any trimester
Rabies	Given if exposure	Any trimester
MMR	Contraindicated	Avoid conception for 4 weeks after vaccination
Varicella	Contraindicated	Avoid conception for 4 weeks
Yellow fever	Generally avoid; give if travel risk outweighs benefit	--
BCG, OPV	Avoid	--

Tetanus in pregnancy (Indian LMIC context):

TT (Tetanus Toxoid) 2 doses, 4 weeks apart, from 16 weeks onward (if previously unimmunized)
Prevents neonatal tetanus

Short 2) Amniotic Fluid Index (AFI)

Definition: A sonographic method to quantify amniotic fluid volume. The uterus is divided into 4 quadrants; the vertical diameter of the largest pocket in each quadrant is measured; AFI = sum of 4 measurements (in cm).

Normal AFI: 8-18 cm (some sources: 5-25 cm)

AFI	Diagnosis	Clinical Significance
>25 cm	Polyhydramnios	Maternal diabetes, fetal anomalies (esophageal atresia, neural tube defects), fetal hydrops
<5 cm	Oligohydramnios	IUGR, post-term pregnancy, renal agenesis (Potter sequence), membrane rupture
5-8 cm	Borderline	Increased monitoring

Single Deepest Pocket (SDP) alternative: Normal = 2-8 cm

Clinical uses:

Non-stress test (NST) component of Biophysical Profile (BPP)
Assessing fetal well-being
Monitoring in high-risk pregnancies (post-dates, IUGR, PROM)

Short 3) Cervical Insufficiency (Incompetent Cervix)

Definition: Inability of the cervix to retain a pregnancy in the absence of uterine contractions; leads to painless, recurrent second-trimester pregnancy loss.

Pathophysiology: Structural weakness of cervical stroma (collagen/elastin defect); fibromuscular incompetence of the internal os.

Risk Factors:

Previous cervical surgery (LEEP, conization, dilatation)
Trauma (forceps delivery, D&C)
Congenital (DES exposure, uterine anomalies)
Connective tissue disorders (Ehlers-Danlos)

Clinical Features:

Recurrent painless mid-trimester losses (14-28 weeks)
Painless dilation of the cervix
Bulging membranes into vagina

Diagnosis:

Primarily clinical/historical
TVS: cervical length <25 mm before 24 weeks (high risk)
Funneling of the internal os on ultrasound ("beaking" sign)

Management:

Cervical cerclage:

McDonald's cerclage (most common) - purse-string suture at cervicovaginal junction
Shirodkar cerclage - higher, submucosal
Timing: prophylactic (12-14 weeks), urgent (dilated cervix with membranes)
Removed at 36-37 weeks

Progesterone:

Vaginal progesterone (200 mg/night) for short cervix (<25 mm) detected incidentally
Reduces preterm birth risk

Arabin pessary: Alternative to cerclage in some centers

Short 4) Anticonvulsants in Pregnancy

Context: Epilepsy affects 0.5% of pregnancies. Key issues: drug teratogenicity vs. risk of uncontrolled seizures (maternal/fetal hypoxia, falls, status epilepticus).

Teratogenic Risks of Common Anticonvulsants:

Drug	Risk	Specific Defects
Valproate	Highest risk (~10% major malformations)	Neural tube defects (spina bifida), cardiac defects, cleft palate, autism, cognitive impairment
Phenytoin	Fetal hydantoin syndrome	Cleft palate, cardiac defects, digit hypoplasia, growth restriction
Carbamazepine	~3-5%	Neural tube defects (1%), craniofacial defects
Phenobarbitone	Moderate	Cardiac, cleft palate
Lamotrigine	Relatively safer	Possible oral clefts at high doses
Levetiracetam	Appears safest	Limited data but favorable profile

Management Principles:

Pre-conception counseling: switch to safer drug, monotherapy at lowest effective dose
Folic acid 5 mg/day from pre-conception through first trimester (all AED patients)
Avoid valproate if possible; if unavoidable, max dose 700-1000 mg/day
Level II ultrasound at 18-20 weeks (anomaly scan)
Vitamin K 10-20 mg/day orally in the last 4 weeks to the mother (enzyme-inducing AEDs deplete neonatal vitamin K)
Neonatal vitamin K 1 mg IM at birth
AED levels may need monitoring (increased volume of distribution in pregnancy alters levels)
Breastfeeding: generally safe; valproate and carbamazepine have low milk transfer

Short 5) Neonatal Jaundice

Definition: Visible jaundice (yellow discoloration) in a newborn due to elevated serum bilirubin (usually >5-7 mg/dL).

Types:

Physiological Jaundice:

Appears on day 2-3, peaks day 4-5, resolves by day 7 (term) or day 14 (preterm)
Bilirubin rarely exceeds 12-15 mg/dL in term infants
Causes: high RBC mass at birth, short RBC lifespan (70-90 days), immature hepatic conjugation (low UDP-glucuronosyltransferase), increased enterohepatic circulation

Pathological Jaundice (requires investigation/treatment):

Feature	Pathological
Onset	<24 hours of life
Bilirubin level	>12-15 mg/dL (term), >10 mg/dL (preterm)
Bilirubin rise	>5 mg/dL per day
Duration	>7 days (term), >14 days (preterm)
Type	Any direct/conjugated hyperbilirubinemia

Causes of Pathological Jaundice:

Hemolytic: Rh incompatibility (erythroblastosis fetalis), ABO incompatibility, G6PD deficiency, hereditary spherocytosis
Infection: sepsis, TORCH infections
Metabolic: hypothyroidism, galactosemia
Cholestatic (direct): biliary atresia, neonatal hepatitis
Breast milk jaundice (prolonged, indirect; benign)

Complications:

Kernicterus (Bilirubin Encephalopathy): Unconjugated bilirubin deposits in basal ganglia, hippocampus, cerebellum
Clinical: Hypotonia -> opisthotonus, seizures -> long-term: choreoathetosis, hearing loss, intellectual disability

Management:

Phototherapy: First-line; blue light (460-490 nm) converts unconjugated bilirubin to water-soluble photoisomers (excreted without conjugation); indications based on gestational age and bilirubin nomogram
Exchange transfusion: For severe hyperbilirubinemia or failure of phototherapy; replaces ~85% of RBCs
IVIG: In Rh/ABO hemolytic disease to reduce hemolysis
Treat underlying cause (antibiotics for sepsis, thyroid hormone for hypothyroidism)

Sources: Textbook of Family Medicine 9e; Robbins Pathology; Gray's Anatomy for Students; Harper's Biochemistry

This is a shared conversation. Sign in to Orris to start your own chat.